Tavira Therapeutics

📍 Leuven, Belgium🗓 Founded 2023👥 3 employees💰 Last funded Apr 2024
Biotechnology Research
LinkedIn
Tavira Therapeutics is a spin-off from KU Leuven developing a modular next-generation AAV capsid platform, with the goal of enhancing tissue-specific transgene delivery for gene therapy
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
1
Frequently asked questions
Who invested in Tavira Therapeutics?
Tavira Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Tavira Therapeutics last raise funding?
The most recent investment in Tavira Therapeutics recorded on gritt.io was in April 2024.
When was Tavira Therapeutics founded?
Tavira Therapeutics was founded in 2023.
What industry is Tavira Therapeutics in?
Tavira Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Tavira Therapeutics based?
Tavira Therapeutics is headquartered in Leuven, Belgium.